Topical Cyanoacrylates Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (2-Octyl Cyanoacrylate, n-Butyl-Cyanoacrylate), By Application (General Surgery, Plastic Surgery and Aesthetic Procedures, Orthopedic, Pediatric, Gynecology, Dental Surgery, Others), By End User (Hospitals, Outpatient Clinics, Home Care Setting, Others), By Region and Competition, 2020-2030F

Market Overview

Global Topical Cyanoacrylates Market was valued at USD 98.62 Million in 2024 and is expected to reach USD 137.50 Million by 2030 with a CAGR of 5.67%. The Global Topical Cyanoacrylates Market is witnessing strong momentum driven by the increasing adoption of advanced wound closure solutions in healthcare systems. Topical cyanoacrylates, widely known as medical-grade adhesives, are gaining preference over traditional sutures and staples due to their ability to provide painless, rapid, and non-invasive closure of surgical incisions and traumatic wounds. Rising prevalence of chronic wounds, burns, and accidental injuries has significantly increased the demand for efficient closure products that minimize infection risks while enhancing healing outcomes. The growing burden of surgical procedures globally, coupled with the rising need for minimally invasive approaches, is also accelerating market growth. Continuous product innovation by manufacturers, focusing on enhanced biocompatibility and improved flexibility, has expanded the scope of applications across pediatric, geriatric, and emergency care settings, further strengthening the adoption of cyanoacrylates as a mainstream wound closure solution.

Key growth drivers include the increasing preference for cost-effective wound management products, the rising burden of traumatic injuries, and the need for reduced hospital stays to lower healthcare costs. Patients and healthcare providers are increasingly favoring topical adhesives as they eliminate the need for removal, reduce scarring, and lower the risk of infections compared to conventional sutures. Technological advancements are also shaping the market, with next-generation cyanoacrylate formulations offering enhanced tensile strength, waterproof properties, and compatibility with sensitive skin. Market players are focusing on expanding their portfolios through research and development, particularly for use in specialized surgeries such as cosmetic, cardiovascular, and orthopedic procedures. Growing awareness regarding infection prevention and patient comfort has also bolstered the demand for these adhesives in both hospital and outpatient care settings.

The market, however, faces challenges that may restrain its growth trajectory in the coming years. The high cost of advanced formulations, particularly in low- and middle-income economies, limits adoption in resource-constrained healthcare systems. Safety concerns regarding skin irritation, allergic reactions, and long-term outcomes in certain patient groups remain critical hurdles. Regulatory complexities for product approvals and compliance with stringent healthcare standards also create barriers for new entrants and delay the introduction of innovative solutions. Limited awareness among healthcare providers in some regions about the benefits of topical cyanoacrylates compared to traditional closure methods further restricts penetration. Despite these obstacles, continuous R&D investments, expanding applications in specialized surgeries, and the growing focus on enhancing post-operative recovery create opportunities for the market to evolve and capture a larger share in global wound care practices. The balance between innovation, affordability, and clinical outcomes will play a decisive role in shaping the growth of the Global Topical Cyanoacrylates Market.

Key Market Drivers

Rising Preference for Minimally Invasive Procedures

The Global Topical Cyanoacrylates Market is gaining strong momentum as healthcare systems worldwide witness a growing preference for minimally invasive procedures over traditional surgical interventions. Patients and providers are prioritizing solutions that reduce trauma, shorten hospital stays, and improve recovery outcomes. Conventional wound closure methods, such as sutures and staples, though effective, are associated with longer healing times, higher risk of infections, scarring, and patient discomfort. In contrast, topical cyanoacrylates provide a fast, painless, and efficient closure method by forming a durable adhesive barrier on the skin surface. This feature makes them particularly suitable for small lacerations, dermatological surgeries, cosmetic procedures, and emergency care settings where speed and safety are critical.

The adoption of cyanoacrylate-based adhesives aligns with the healthcare industry’s broader shift toward outpatient and ambulatory services, which are designed to optimize costs and enhance patient experiences. According to the Agency for Healthcare Research and Quality (AHRQ), approximately 12.4 million ambulatory surgery encounters were recorded in the United States in 2022, reflecting the increasing reliance on outpatient interventions. This surge in outpatient volumes is creating higher demand for wound closure solutions that are less invasive, require minimal post-procedure care, and allow patients to return to daily activities quickly. Cyanoacrylates address these requirements effectively, making them a preferred choice in hospitals, ambulatory surgical centers, and emergency departments.

In pediatric and geriatric care, the appeal of topical cyanoacrylates is even stronger. Pediatric patients often experience anxiety and distress with suturing, while older patients may have fragile skin that heals poorly when subjected to invasive closure techniques. The ability of cyanoacrylates to provide secure closure without additional trauma improves patient compliance and outcomes across these sensitive groups. Cosmetic and plastic surgeons are also driving adoption, as the adhesives help achieve cleaner aesthetic results with reduced scarring, aligning with the rising demand for procedures where visual outcomes are highly valued.

Increasing Surgical Volumes and Trauma Cases

The Global Topical Cyanoacrylates Market is experiencing robust expansion driven by the escalating volume of surgical procedures worldwide. A recent analysis reveals that 56.9% of nations now consistently report surgical metrics, marking a substantial increase since 2016. Current global surgical volume remains far below the Lancet Commission on Global Surgery’s target of at least 5,000 procedures per 100,000 population, with only 36.6% of reporting countries having achieved that threshold. This gap underscores a rising demand for efficient wound closure methods to accommodate growing surgical workloads, a demand well-met by topical cyanoacrylates, which offer quick, painless closure with strong adhesion, reducing postoperative infection and improving cosmetic outcomes.

Simultaneously, the burden of trauma, particularly from road traffic accidents continues to place significant pressure on healthcare systems. In 2021, the World Health Organization reported approximately 1.19 million annual road traffic fatalities globally, translating to over 3,200 deaths per day. This alarming rate of traumatic injuries necessitates rapid, reliable wound management tools. Topical cyanoacrylates, with their ease of application and strong sealing capability, are increasingly favored in urgent care settings, including emergency rooms and field deployments.

Combined, the surge in surgical interventions and persistent trauma cases are fueling a critical need for advanced, patient-friendly wound closure solutions. Topical cyanoacrylates, with their pain-free use, reduced scarring, and infection control properties, are being adopted more widely as a modern alternative to sutures. The growing usage by healthcare professionals aims to enhance procedural efficiency, patient comfort, and clinical outcomes making topical cyanoacrylates an integral component in modern wound care across diverse medical settings.

Growing Adoption in Outpatient and Ambulatory Care

A key growth driver for the Global Topical Cyanoacrylates Market lies in their expanding adoption across outpatient and ambulatory care settings. The U.S. healthcare landscape highlights the rise in physician–patient interactions outside hospital environments, with approximately 1.0 billion visits to physician offices in 2024, equating to 320.7 visits per 100 persons, of which 50.3% were handled by primary care providers. This underscores the increasing reliance on outpatient facilities and ambulatory services, critical contexts where topical cyanoacrylates excel as rapid, efficient wound closure solutions.

These adhesives align perfectly with the operational needs of high-volume outpatient clinics. Their ease of use significantly reduces procedural duration, enabling clinicians to manage larger patient volumes without compromising on care quality. Patients benefit from less pain during application, decreased infection risks, and enhanced aesthetic outcomes due to minimal scarring. The elimination of follow-up visits for suture removal further streamlines care, raising overall patient satisfaction.

As healthcare systems transition toward value-based models emphasizing efficiency, patient comfort, and cost-effectiveness, topical cyanoacrylates emerge as ideal tools. They support ambulatory settings by simplifying wound management, improving throughput, and aligning with patient-centered care goals. The escalating number of outpatient visits documented by government sources reinforces the imperative for solutions that cater to high-frequency, low-complexity procedures. In such environments, topical cyanoacrylates stand out for their practicality, safety, and patient appeal, fueling their adoption and driving market momentum in the years ahead.

Download Free Sample Report

Key Market Challenges

Risk of Cytotoxicity and Tissue Irritation

One of the major challenges restraining the growth of the Global Topical Cyanoacrylates Market is the risk of cytotoxicity and tissue irritation associated with their application. While these adhesives provide fast and effective wound closure, the chemical composition and polymerization process can sometimes release byproducts that negatively impact surrounding tissues. In certain cases, patients experience localized inflammation, redness, or burning sensations at the wound site, which can compromise healing outcomes. This risk is more pronounced in individuals with sensitive skin, pediatric patients, or those with pre-existing dermatological conditions. Prolonged or repeated exposure may also increase the likelihood of adverse reactions, raising concerns about their suitability for widespread use across diverse patient populations. Medical professionals often exercise caution when selecting cyanoacrylate products, as potential irritation can deter adoption despite the convenience and cosmetic benefits these adhesives offer. The perception of safety is critical in wound care, and any evidence of cytotoxicity can influence both clinical decision-making and patient trust in such products.

Manufacturers face the ongoing challenge of innovating safer formulations that retain strong adhesive properties while minimizing harmful effects on tissues. This has led to increased research efforts aimed at reducing toxicity levels, enhancing biocompatibility, and incorporating additives that can soothe irritation. However, the regulatory process for approving such innovations is rigorous and time-intensive, slowing down market penetration of improved variants. Until advancements fully address these safety concerns, the risk of tissue irritation and cytotoxicity will remain a key barrier limiting the broader adoption of topical cyanoacrylates in both clinical and consumer healthcare settings, thereby impacting the overall growth potential of the market.

Limited Suitability for High-Tension or Deep Wounds

One of the key challenges faced by the Global Topical Cyanoacrylates Market is their limited suitability for high-tension or deep wounds, which restricts their application in more complex surgical and trauma care scenarios. Topical cyanoacrylates are highly effective for superficial lacerations and low-tension wound closures, but when used on wounds that experience significant mechanical stress or require closure at deeper tissue levels, they often fail to provide the necessary tensile strength and durability. This limitation can result in wound dehiscence, delayed healing, or the need for additional closure techniques such as sutures or staples, which diminishes their appeal in certain clinical settings. Surgeons treating large, irregular, or contaminated wounds may hesitate to rely solely on cyanoacrylate adhesives, as inadequate closure could lead to complications such as infections, scarring, or prolonged recovery times. The restricted scope of application also creates hesitancy among healthcare providers to adopt these products universally, particularly in emergency departments and trauma care units where wounds vary in complexity and severity.

Manufacturers are exploring advanced formulations and hybrid solutions that integrate cyanoacrylates with other closure methods, but the current limitations continue to narrow the market potential compared to sutures and staples, which remain the gold standard for high-tension closures. For cyanoacrylates to achieve broader clinical acceptance, significant advancements in adhesive strength, flexibility, and compatibility with deeper tissue layers are required. Until then, the reliance on these adhesives will remain concentrated in specific areas such as dermatology, pediatrics, and minor surgical procedures. The inability to address high-tension or deep wounds represents a substantial hurdle for market expansion, as it prevents cyanoacrylates from being positioned as a universal wound closure solution, thereby slowing their adoption in critical and high-demand surgical applications.

Key Market Trends

Rising Preference for Non-Invasive Wound Closure Solutions

The Global Topical Cyanoacrylates Market is experiencing a strong shift driven by the rising preference for non-invasive wound closure solutions, as healthcare providers and patients increasingly seek alternatives to traditional sutures and staples. Topical cyanoacrylates are gaining prominence due to their ability to provide rapid wound closure without penetrating the skin, which reduces procedural time, minimizes patient discomfort, and lowers the risk of complications such as infections or suture-related trauma. This trend is being amplified in emergency care, dermatology, cosmetic surgery, and pediatric applications, where aesthetics, safety, and efficiency are highly valued.

The use of cyanoacrylate adhesives not only delivers functional closure but also supports faster recovery, less scarring, and improved patient satisfaction, making them a preferred choice in modern wound management practices. Hospitals and outpatient facilities are increasingly adopting these adhesives as they align with the growing demand for minimally invasive procedures and reduced hospital stays. Patients also favor non-invasive methods that offer improved cosmetic outcomes, which is driving their wider acceptance across both developed and emerging healthcare markets. The combination of clinical benefits, reduced procedure complexity, and patient-centric outcomes is strengthening the global adoption of topical cyanoacrylates as an essential tool in wound care and surgical applications, shaping the future of wound closure technologies.

Increasing Adoption in Pediatric and Geriatric Care

The increasing adoption of topical cyanoacrylates in pediatric and geriatric care is emerging as a significant trend in the Global Topical Cyanoacrylates Market, driven by the unique clinical needs of these patient populations. Children and elderly patients often have delicate and sensitive skin that is prone to tearing, irritation, or slow healing, making traditional sutures and staples less suitable. Topical cyanoacrylates offer a gentle, non-invasive alternative that minimizes trauma during wound closure, reduces the risk of infection, and accelerates recovery. In pediatric care, these adhesives are widely used for minor cuts, lacerations, and surgical incisions, as they eliminate the pain and anxiety associated with needle-based suturing. For geriatric patients, who often suffer from chronic conditions like diabetes or vascular disorders that impair wound healing, cyanoacrylates provide secure and durable closure while minimizing additional stress on fragile skin.

Healthcare providers are increasingly recognizing the clinical advantages of these adhesives in outpatient and emergency care settings, where rapid, efficient, and safe wound management is critical. Cyanoacrylate adhesives facilitate faster procedural times, reduce the need for follow-up visits for suture removal, and help maintain patient comfort, which is particularly important in populations with limited mobility or heightened sensitivity. Advances in adhesive formulations, including improved flexibility, reduced cytotoxicity, and incorporation of antimicrobial properties, have further supported their adoption in pediatric and geriatric applications. The trend is also being reinforced by training programs for clinicians and growing awareness among caregivers about the benefits of cyanoacrylates. As healthcare systems continue to prioritize patient-centered care and seek solutions that enhance healing outcomes while minimizing complications, the use of topical cyanoacrylates in pediatric and geriatric populations is expected to expand, driving market growth in these segments over the coming years.

Segmental Insights

Product Insights

Based on the Product, 2-Octyl Cyanoacrylate emerged as the dominant segment in the Global Topical Cyanoacrylates Market in 2024. This is due to its superior clinical performance and widespread adoption across surgical and emergency care settings. This medical-grade adhesive is preferred over traditional cyanoacrylate formulations because of its enhanced flexibility, reduced tissue toxicity, and ability to provide strong, durable wound closure. 2-Octyl Cyanoacrylate forms a protective barrier over incisions and lacerations, minimizing the risk of infection while promoting faster healing and improved cosmetic outcomes. Its low exothermic reaction during polymerization reduces patient discomfort and makes it suitable for use on sensitive skin, including pediatric and geriatric patients.

End User Insights

Based on the End User, Hospitals emerged as the dominant segment in the Global Topical Cyanoacrylates Market in 2024. This dominance is due to their high procedural volumes and the critical need for efficient, reliable wound closure solutions. Hospitals perform a wide range of surgical interventions, emergency treatments, and trauma care procedures that require rapid and effective wound management. Topical cyanoacrylates are increasingly preferred in these settings because they offer non-invasive closure, minimize infection risks, reduce procedural time, and improve patient comfort, making them particularly valuable in high-throughput environments. The hospital segment’s dominance is further strengthened by the adoption of advanced 2-Octyl Cyanoacrylate formulations, which provide superior flexibility, durability, and biocompatibility compared to traditional adhesives.

Download Free Sample Report

Regional Insights

North America emerged as the dominant region in the Global Topical Cyanoacrylates Market in 2024. This is primarily driven by advanced healthcare infrastructure, strong adoption of innovative medical technologies, and high surgical procedure volumes. The region has well-established hospitals, outpatient centers, and emergency care facilities that increasingly rely on topical cyanoacrylates for efficient wound closure. These adhesives are widely preferred over traditional sutures and staples because they reduce procedural time, lower infection risks, and enhance patient comfort, aligning with the region’s focus on improving clinical outcomes and patient satisfaction. The dominance of North America is also supported by the presence of major market players and extensive R&D initiatives aimed at developing advanced formulations such as 2-Octyl Cyanoacrylate, which offers enhanced flexibility, biocompatibility, and antimicrobial properties. High awareness among healthcare professionals regarding the benefits of cyanoacrylate adhesives, coupled with strong regulatory support and reimbursement frameworks, further accelerates adoption.

Recent Developments

• In August 2024, Resivant Medical announced that it had secured U.S. Food and Drug Administration (FDA) 510(k) clearance for its first two products: the Cutiva Topical Skin Adhesive and the Cutiva PLUS Skin Closure System. The latter combines an adhesive mesh patch with a high-viscosity Cutiva liquid adhesive, offering an innovative solution for wound closure. This regulatory clearance enables Resivant Medical to commercially launch these products in the United States, targeting both surgical and emergency care applications.
• In September 2023, Advanced Medical Solutions Group plc (AMS) entered into a commercialization agreement with TELA Bio, Inc., a U.S.-based developer of soft-tissue reconstruction solutions. This collaboration focuses on bringing LiquiBandFix8 to the U.S. market, expanding AMS’s footprint in surgical tissue adhesives. LiquiBandFix8 received FDA Pre-Market Approval (PMA) in June 2023 for hernia repair procedures. Unlike conventional metal tacks used to secure surgical mesh, LiquiBandFix8 utilizes precise drops of cyanoacrylate adhesive for both open and laparoscopic surgeries.
• In June 2023, LiquiBandFix8/LIQUIFIX secured Pre-Market Approval (PMA) from the U.S. Food and Drug Administration (FDA) for use in hernia repair procedures, marking a significant milestone in surgical adhesive technology. Unlike traditional methods that rely on metal tacks to fix surgical mesh, the device utilizes precise drops of cyanoacrylate adhesive to secure the mesh to tissue during both open and laparoscopic hernia surgeries. This innovative approach provides a less invasive alternative, potentially reducing patient discomfort, minimizing post-operative pain, and lowering the risk of complications commonly associated with mechanical fixation.
• In May 2023, H.B. Fuller Company, the world’s largest pureplay adhesives manufacturer, acquired Adhezion Biomedical, a privately held U.S. medical adhesives company with operations in over 40 countries and more than 35 international certifications, including 105 patents. Adhezion specializes in proprietary cyanoacrylate technologies for surgical procedures, wound care, and infection prevention.
• In February 2023, AMS further expanded its tissue adhesive portfolio through the acquisition of Connexicon Medical Limited, a specialist in cyanoacrylate technologies. The deal included an initial payment of USD 8.07 million, with additional deferred payments tied to R&D, regulatory, and commercial milestones through 2027. This acquisition reinforces AMS’s position in the USD 300 million global tissue adhesive market, broadens its product portfolio, and strengthens its technical and research capabilities in cyanoacrylate-based medical adhesives.

Key Market Players

• Medline Industries, LP
• Advanced Medical Solutions Group plc
• H.B. Fuller Medical Adhesive Technologies, LLC
• Meril Life Sciences Pvt. Ltd.
• Ethicon, Inc. (Johnson & Johnson MedTech)
• Medtronic plc
• Alfa Pharma GmbH
• Epiglue Pharma Pvt. Ltd.
• B.Braun SE
• Resivant Medical LLC

Report Scope:

In this report, the Global Topical Cyanoacrylates Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Topical Cyanoacrylates Market, By Product:

o   2-Octyl Cyanoacrylate

o   n-Butyl-Cyanoacrylate

• Topical Cyanoacrylates Market, By Application:

o   General Surgery

o   Plastic Surgery and Aesthetic Procedures

o   Orthopedic

o   Pediatric

o   Gynecology

o   Dental Surgery

o   Others

• Topical Cyanoacrylates Market, By End User:

o   Hospitals

o   Outpatient Clinics

o   Home Care Setting

o   Others

• Topical Cyanoacrylates Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia-Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Topical Cyanoacrylates Market.

Available Customizations:

Global Topical Cyanoacrylates Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Topical Cyanoacrylates Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]